Skip to main content
. Author manuscript; available in PMC: 2010 Sep 7.
Published in final edited form as: J Thromb Haemost. 2009 Apr 2;7(6):911–918. doi: 10.1111/j.1538-7836.2009.03360.x

Table 2.

Criteria used to evaluate causative relationships in drug-induced thrombocytopenic purpura*

Criterion Description
1 Therapy with the candidate drug preceded thrombocytopenia.
2 Recovery from thrombocytopenia was complete and sustained after therapy with the drug was discontinued.
2 The candidate drug was the only drug used before the onset of thrombocytopenia or other drugs were continued or re-introduced after discontinuation of therapy with the candidate drug with a sustained normal platelet count.
3 Other causes for thrombocytopenia were excluded.
4 Re-exposure to the candidate drug resulted in recurrent thrombocytopenia.
Level of Evidence
I Definite: Criteria 1, 2, 3 and 4 are met.
II Probable: Criteria 1, 2, and 3 are met.
III Possible: Criterion 1 met.
IV Unlikely: Criterion 1 not met.
*

Adapted from JN George et al (49)